Tuesday, January 03, 2023 6:00:00 PM
Just got a chance to look at this (downloaded the article).
https://www.reddit.com/r/RVVTF/comments/101z7y6/targeting_sarscov2_by_synthetic_dualacting_thiol/
Posted by u/_nicktendo_64
Here is the article:
https://faseb.onlinelibrary.wiley.com/doi/pdfdirect/10.1096/fj.202201157RR
Right off the bat it clearly says NAC and Bucillamine are gangbuster ways to fight the Covid crud and other viruses..
"The environmental redox state is an important factor for
enveloped viruses' life cycle. The thiol–disulfide balance
plays an important role in receptor recognition by the
SARS-CoV-2 spike (S) protein. Given that a correct protein
conformation is required for protein function and that disulfide bonds are often crucial both for structural stability and conformational changes, it is not surprising that
the reduction of the disulfides into sulfhydryl groups in
the receptor binding domain (RBD) seriously impairs the
binding to ACE2.
1,2 Thus, manipulation of the redox status of the cysteine-rich glycoproteins in the virus envelope can influence viral cell entry.
Cleavage of disulfide bonds by thiol-reducing compounds can efficiently weaken viral binding and prevent SARS-CoV-2 infection"
https://www.reddit.com/r/RVVTF/comments/101z7y6/targeting_sarscov2_by_synthetic_dualacting_thiol/
Posted by u/_nicktendo_64
Here is the article:
https://faseb.onlinelibrary.wiley.com/doi/pdfdirect/10.1096/fj.202201157RR
Right off the bat it clearly says NAC and Bucillamine are gangbuster ways to fight the Covid crud and other viruses..
"The environmental redox state is an important factor for
enveloped viruses' life cycle. The thiol–disulfide balance
plays an important role in receptor recognition by the
SARS-CoV-2 spike (S) protein. Given that a correct protein
conformation is required for protein function and that disulfide bonds are often crucial both for structural stability and conformational changes, it is not surprising that
the reduction of the disulfides into sulfhydryl groups in
the receptor binding domain (RBD) seriously impairs the
binding to ACE2.
1,2 Thus, manipulation of the redox status of the cysteine-rich glycoproteins in the virus envelope can influence viral cell entry.
Cleavage of disulfide bonds by thiol-reducing compounds can efficiently weaken viral binding and prevent SARS-CoV-2 infection"
Bullish
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
